Inflection Point Ventures (IPV) led the pre-series A round of funding for Welcome Cure, which totaled over 4 crores. The startup from Mumbai hopes to raise more than 16 crores during this current funding round.
According to a press release from Welcome Cure, the money will be used for growth, including talent acquisition, technology improvement, and marketing initiatives.
Welcome Cure, a fully integrated homeopathy technology firm founded by Jawahar Shah, Punit Desai, and Nidhi Desai, provides solutions powered by artificial intelligence (AI) for doctors and patients, ensuring both efficient prescriptions and convenient access to healthcare wherever they may be.
The startup claims to have 2.5 million platform users and over 1.5 million patients registered across more than 36 nations. Over 14,000 doctors in 140 countries are served by the company’s software division.
Through more than 190 deals, IPV has already invested more than Rs 600 crore. In 2023, it supported several companies, including Answer Genomics, Oorjaa, 13SQFT.com, Beyobo, Dusminute, and InsideFPV.
